MEASURING THE PHYSICAL STABILITY OF SUBUNIT VACCINES
Avacta?s Optim 2 instrument provides a practical solution for determining the conformational stability of adjuvant bound vaccines, eliminating the need for awkward and time consuming standard analytical techniques. [more?..]
MEASURING THE PHYSICAL STABILITY OF SUBUNIT VACCINES
Measuring the stability of adjuvant bound vaccines has long been an awkward and time consuming task. Standard analytical techniques are hindered by low sample throughput, the need for large sample volumes and a requirement for rigorous cleaning between measurements.
In our downloadable application note we investigate how Avacta’s Optim 2 instrument is able to determine changes in the conformational stability of model proteins, both in solution and when adsorbed to an aluminium hydroxide adjuvant. We also review the instruments capabilities for making these measurements in a high throughput manner, using small volume (9ul) samples and removing the need to clean between measurements.
Please click this link to the download the application note http://www.avactaanalytical.com/subunit-vaccines-download
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
